Relapsed and Refractory Follicular Lymphoma Clinical Trials in Guangzhou, Guangdong

Orelabrutinib Plus Rituximab Followed by Maintenance With Orelabrutinib for Relapsed and Refractory Follicular Lymphoma(RR FL)